The most effective surgery for trigeminal neuralgia is microvascular decompression (MVD), a procedure that physically separates a blood vessel from the trigeminal nerve to stop the pain at its source. About 80% of patients have excellent results one year after MVD, and 70% remain completely pain-free at 10 years without medication. But MVD isn’t the only option. Several less invasive procedures exist for people who aren’t good candidates for open surgery, each with different trade-offs in durability, recovery time, and side effects.
Why Surgery Becomes Necessary
Trigeminal neuralgia typically starts as episodes of intense, shock-like facial pain triggered by ordinary activities like chewing, talking, or even a light breeze. Most people begin treatment with medications that calm overactive nerve signals. When those medications stop working, cause intolerable side effects, or never provided adequate relief in the first place, surgery becomes the next step.
Before any procedure, specialized MRI sequences help surgeons see exactly what’s happening. A technique called FIESTA imaging produces remarkably detailed pictures of the trigeminal nerve and surrounding blood vessels, allowing the surgical team to identify which vessel is pressing on the nerve, how much the nerve is displaced, and whether a structural problem like a tumor or cyst is involved. This imaging directly shapes which surgery is recommended.
Microvascular Decompression (MVD)
MVD is the gold standard because it treats the underlying cause rather than simply damaging the nerve to block pain signals. In most cases of trigeminal neuralgia, a blood vessel (usually an artery near the brainstem) presses against the trigeminal nerve, wearing away its protective insulation over time. MVD physically moves that vessel away and keeps it there permanently.
The surgery is performed under general anesthesia. A surgeon makes a small opening in the skull behind the ear, then opens the protective covering of the brain to reach the area where the trigeminal nerve exits the brainstem. Using a surgical microscope, the team identifies the nerve and carefully separates the offending blood vessel from its surface. The superior cerebellar artery is the most common culprit, though other arteries and veins can also be responsible. Once the vessel is freed, a small piece of Teflon felt is placed between the vessel and the nerve to keep them apart.
The results are durable. A landmark study published in the New England Journal of Medicine found that the recurrence rate drops below 2% per year by year five and below 1% by year ten. Most people feel pain relief immediately after surgery. Hospital stays run one to two nights, with soreness lasting one to two weeks. You can typically return to your normal routine in about a month, though strenuous physical activity should wait four to six weeks.
MVD is generally recommended for patients under 65 who are in good overall health. Elderly patients or those with significant medical conditions are usually steered toward less invasive alternatives.
Percutaneous Rhizotomy Procedures
These three needle-based procedures work by deliberately damaging the trigeminal nerve to interrupt pain signals. They’re performed through the cheek, guided by imaging, with the needle reaching the nerve through a natural opening at the base of the skull. All three are outpatient or short-stay procedures with faster recovery than MVD, but pain is more likely to return over time.
Balloon Compression
A tiny balloon is inflated against the nerve for a short period, injuring the pain-carrying fibers. Of the three rhizotomy options, balloon compression provides the highest initial success rate (86% achieve complete pain relief) and the longest-lasting results. The trade-off is a higher complication rate at about 44%, though most complications are minor and temporary, primarily facial numbness. Patients with heart conditions are not ideal candidates because the procedure can cause changes in heart rhythm and blood pressure during the operation.
Radiofrequency Thermocoagulation
An electrode heats the nerve fibers to selectively destroy the ones carrying pain. Initial complete pain relief occurs in about 80% of patients, with a complication rate around 27%. One advantage: if pain returns, repeat procedures work just as well as the first time.
Glycerol Injection
A chemical called glycerol is injected into the fluid-filled space surrounding the nerve, damaging the pain fibers. Initial success rates are lower at about 72%, and repeat injections tend to provide shorter relief than the first treatment. The complication rate sits at about 30%. Glycerol injection carries a lower risk of jaw muscle weakness, making it a better fit for patients who already have difficulty with jaw movement or temporomandibular joint problems.
Gamma Knife Radiosurgery
Despite the name, Gamma Knife involves no incision at all. Highly focused beams of radiation are aimed at the trigeminal nerve root, gradually damaging the nerve enough to reduce pain signals. The procedure is completely noninvasive: you wear a specialized head frame, and the treatment takes place in a single session.
Pain relief takes longer to appear compared to other surgeries. The average time to relief is about seven days, but it can take up to 40 days in some cases. About 93% of patients experience significant pain relief initially, and roughly 70% still have meaningful improvement three years later. Gamma Knife is an option for patients of any age and health status, making it particularly useful for people who can’t tolerate anesthesia or open surgery.
Internal Neurolysis: When No Vessel Is Found
Sometimes imaging or even direct surgical exploration reveals no blood vessel compressing the nerve. These patients aren’t candidates for MVD. Internal neurolysis, first described in 1995 as “nerve combing,” offers an alternative. The surgeon longitudinally separates the individual fiber bundles within the trigeminal nerve, disrupting the abnormal signaling that causes pain without cutting the nerve itself.
This technique appears to be more durable than radiofrequency ablation and achieves higher pain-free rates than radiosurgery. It’s also used for patients whose pain has returned after a previous MVD.
How Surgeons Choose the Right Procedure
The decision depends on several overlapping factors. Age, overall health, the specific cause of pain, and which branch of the trigeminal nerve is affected all play a role.
- Younger, healthy patients with confirmed vascular compression: MVD is the first choice because it offers the best chance of permanent cure without intentional nerve damage.
- Older patients or those with significant health conditions: Percutaneous procedures or Gamma Knife radiosurgery provide relief with lower surgical risk.
- Patients without vascular compression: Internal neurolysis or one of the rhizotomy options, since MVD wouldn’t have a target vessel to move.
- Patients who want to avoid any invasive procedure: Gamma Knife, which requires no anesthesia and no incision.
Risks Across All Procedures
Facial numbness is the most common side effect of trigeminal neuralgia surgery regardless of technique. In repeat MVD cases, numbness occurs in nearly 69% of patients, and it can be long-lasting. Other complications include blurred vision (about 7.5% of cases) and hearing changes (about 5.4%), particularly with procedures that work near the brainstem.
The procedures that intentionally damage the nerve (all three rhizotomy types and Gamma Knife) carry a higher likelihood of permanent numbness because nerve injury is the mechanism of action. MVD has the advantage of preserving normal nerve function since it addresses the compression without harming the nerve itself, but it carries the typical risks of any surgery near the brain, including infection and, rarely, cerebrospinal fluid leaks.